Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)
Sponsor: Benedito Mauro Rossi
Summary
This study is being conducted to better understand how pancreatic cancer behaves during treatment and how we can improve methods for monitoring disease progression. The research aims to determine whether small molecules present in the blood, called miRNAs, can help doctors assess whether the treatment is working or needs adjustment. With this, we hope to make cancer monitoring less invasive and more precise, allowing patients to receive more personalized and effective treatments.
Official title: Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2025-01-21
Completion Date
2027-12
Last Updated
2025-04-27
Healthy Volunteers
No
Conditions
Locations (1)
A Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil